SSGJ-707
SSGJ-707-NSCLC-II-02
Phase 2 small_molecule active
Quick answer
SSGJ-707 for First-line Advanced NSCLC Patients is a Phase 2 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- First-line Advanced NSCLC Patients
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active